The impact of age and gender on the striatal astrocytes activation in murine model of Parkinson's disease

Inflammation Research

Volumn 58, Issue 11, 2009, Pages 747-753

  Ciesielska, Agnieszka ^a,b   Joniec, I ^b   Kurkowska Jastrzebska I ^a   Cudna, A ^b   Przybylkowski A ^b   Czlonkowska A ^a,b   Czlonkowski A ^b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Aging; Astrogliosis; Gender; Inflammatory response; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; MALE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STRIATE CORTEX; UTERUS WEIGHT; WESTERN BLOTTING;

AGING; ANIMALS; ASTROCYTES; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; PARKINSON DISEASE; RNA, MESSENGER;

EID: 70349958031     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0026-6     Document Type: Article

References (33)

1. T Bordia SR Grady JM McIntosh M Quik 2007 Nigrostriatal damage preferentially decreases a subpopulation of alpha6beta2 nAChRs in mouse, monkey, and Parkinson's disease striatum Mol Pharmacol 72 52 61 17409284 10.1124/mol.107.035998 1:CAS:528:DC%2BD2sXnsVyjsL4%3D (Pubitemid 46998524)
2. I Kurkowska-Jastrzebska A Wrońska M Kohutnicka A Członkowski AT Członkowska 1999 The inflammatory reaction following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxication in mouse Exp Neurol 156 50 61 10192776 10.1006/exnr.1998.6993 1:CAS:528: DyaK1MXis1equrk%3D (Pubitemid 29152982)
3. LW Chen KL Yung YS Chan 2005 Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease Curr Drug Targets 6 821 833 16305461 10.2174/138945005774574506 1:CAS:528:DC%2BD2MXhtFCgt7jI (Pubitemid 41472496)
4. T Himeda Y Watanabe H Tounai N Hayakawa H Kato T Araki 2006 Time-dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice J Neural Transm 113 1887 1894 16736245 10.1007/s00702-006- 0482-x 1:CAS:528:DC%2BD28Xht1Sgu7vJ (Pubitemid 44749629)
5. H Kato R Kurosaki C Oki T Araki 2004 Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice Brain Res 1030 66 73 15567338 10.1016/j.brainres.2004.09. 046 1:CAS:528:DC%2BD2cXhtVantL7K (Pubitemid 39563827)
6. RM Solano MJ Casarejos J Menéndez-Cuervo JA Rodriguez-Navarro J García de Yébenes MA Mena 2008 Glial dysfunction in parkin null mice: effects of aging J Neurosci 28 598 611 18199761 10.1523/JNEUROSCI.4609-07. 2008 1:CAS:528:DC%2BD1cXhtFejtLg%3D (Pubitemid 351159033)
7. M Pekny M Pekna 2004 Astrocyte intermediate filaments in CNS pathologies and regeneration J Pathol 204 428 437 15495269 10.1002/path.1645 1:CAS:528:DC%2BD2cXhtVCgsrvJ (Pubitemid 39468154)
8. JP O'Callaghan K Sriram 2005 Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity Expert Opin Drug Saf 4 433 442 15934851 10.1517/14740338.4.3.433 (Pubitemid 40723718)
9. JA Sloane W Hollander DL Rosene MB Moss T Kemper CR Abraham 2000 Astrocytic hypertrophy and altered GFAP degradation with age in subcortical white matter of the rhesus monkey Brain Res 862 1 10 10799662 10.1016/S0006-8993(00)02059-X 1:CAS:528:DC%2BD3cXivVGhtL8%3D (Pubitemid 30229764)
10. JA Chowen S Busiguina LM García-Segura 1995 Sexual dimorphism and sex steroid modulation of glial fibrillary acidic protein messenger RNA and immunoreactivity levels in the rat hypothalamus Neuroscience 69 519 532 8552246 10.1016/0306-4522(95)00250-M 1:CAS:528:DyaK2MXptVOjt7w%3D
11. I Rozovsky M Wei DJ Stone H Zanjani CP Anderson TE Morgan CE Finch 2002 Estradiol (E2) enhances neurite outgrowth by repressing glial fibrillary acidic protein expression and reorganizing laminin Endocrinology 143 636 646 11796520 10.1210/en.143.2.636 1:CAS:528:DC%2BD38XosFajsg%3D%3D (Pubitemid 34107219)
12. A Ciesielska I Joniec I Kurkowska-Jastrzebska A Przybyłkowski G Gromadzka A Członkowska A Członkowski 2007 Influence of age and gender on cytokine expression in a murine model of Parkinson's disease Neuroimmunomodulation 14 255 265 18196934 10.1159/000113432 1:CAS:528: DC%2BD1cXislSmu7c%3D (Pubitemid 351339992)
13. I Joniec A Ciesielska I Kurkowska-Jastrzebska A Przybyłkowski A Członkowska A Członkowski 2009 Age- and sex- differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Brain Research 1261 7 19 10.1016/j.brainres.2008.12.081 1:CAS:528: DC%2BD1MXivVehsrs%3D
14. S Przedborski V Jackson-Lewis AB Naini M Jakowec G Petzinger R Miller M Akram 2001 The parkinsonian toxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP): a technical review of its utility and safety J Neurochem 76 1265 1274 11238711 10.1046/j.1471-4159.2001.00183.x 1:CAS:528:DC%2BD3MXhvVCjtLw%3D (Pubitemid 32198231)
15. Y Wu AQ Zhang DT Yew 2005 Age-related changes of various markers of astrocytes in senescence-accelerated mice hippocampus Neurochem Int 46 565 574 15843051 10.1016/j.neuint.2005.01.002 1:CAS:528:DC%2BD2MXjsVGmsLg%3D (Pubitemid 40544404)
16. DE Dluzen C Tweed LI Anderson NJ Laping 2003 Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigro-striatal dopaminergic system Neuroendocrinology 77 232 238 12766323 10.1159/000070278 1:CAS:528:DC%2BD3sXktVKntL8%3D (Pubitemid 36667657)
17. MC Morale PA Serra F L'episcopo C Tirolo S Caniglia N Testa F Gennuso G Giaquinta G Rocchitta MS Desole E Miele B Marchetti 2006 Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration Neuroscience 138 869 878 16337092 10.1016/j.neuroscience.2005.07.060 1:CAS:528:DC%2BD28XitVGjtL4%3D (Pubitemid 43306827)
18. D Garcia-Ovejero I Azcoitia LL Doncarlos RC Melcangi LM Garcia-Segura 2005 Glia-neuron cross-talk in the neuroprotective mechanisms of sex steroid hormones Brain Res Brain Res Rev 48 273 286 15850667 10.1016/j.brainresrev.2004. 12.018 1:CAS:528:DC%2BD2MXjs1Cmu70%3D (Pubitemid 40585759)
19. FG Martinez EE Hermel LL Xavier GG Viola J Riboldi AA Rasia-Filho M Achaval 2006 Gonadal hormone regulation of glial fibrillary acidic protein immunoreactivity in the medial amygdala subnuclei across the estrous cycle and in castrated and treated female rats Brain Res 1108 117 126 16842763 10.1016/j.brainres.2006.06.014 1:CAS:528:DC%2BD28XovVShur4%3D (Pubitemid 44278012)
20. RG Struble BP Nathan C Cady X Cheng M McAsey 2007 Estradiol regulation of astroglia and apolipoprotein E: an important role in neuronal regeneration Exp Gerontol 42 54 63 16837159 10.1016/j.exger.2006.05.013 1:CAS:528: DC%2BD2sXhsFamsw%3D%3D (Pubitemid 44937823)
21. H Riol C Fages M Tardy 1992 Transcriptional regulation of glial fibrillary acidic protein (GFAP)-mRNA expression during postnatal development of mouse brain J Neurosci Res 32 79 85 1629945 10.1002/jnr.490320110 1:CAS:528:DyaK38XisFarsbg%3D
22. M Brenner A Messing 1996 GFAP transgenic mice Methods 10 351 364 8954847 10.1006/meth.1996.0113 1:CAS:528:DyaK28XmslKntLo%3D (Pubitemid 26391934)
23. TC e Spohr R Martinez EF da Silva VM Neto FC Gomes 2002 Neuro-glia interaction effects on GFAP gene: a novel role for transforming growth factor-beta1 Eur J Neurosci 16 2059 2069 10.1046/j.1460-9568.2002.02283.x (Pubitemid 35454250)
24. S Tsukahara S Tanaka K Ishida N Hoshi H Kitagawa 2005 Age-related change and its sex differences in histoarchitecture of the hypothalamic suprachiasmatic nucleus of F344/N rats Exp Gerontol 40 147 155 15763391 10.1016/j.exger.2004. 10.003 (Pubitemid 40343005)
25. V Sarthy H Egal 1995 Transient induction of the glial intermediate filament protein gene in Müller cells in the mouse retina DNA Cell Biol 14 313 320 7710688 10.1089/dna.1995.14.313 1:CAS:528:DyaK2MXltVaksbo%3D
26. LM Shulman 2007 Gender differences in Parkinson's disease Gend Med 4 8 18 17584622 10.1016/S1550-8579(07)80003-9 (Pubitemid 46917063)
27. K Xu Y Xu D Brown-Jermyn JF Chen A Ascherio DE Dluzen MA Schwarzschild 2006 Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease J Neurosci 26 535 541 16407551 10.1523/JNEUROSCI.3008-05.2006 1:CAS:528: DC%2BD28XosFWrtA%3D%3D (Pubitemid 43237118)
28. DB Miller SF Ali JP O'Callaghan SC Laws 1998 The impact of gender and estrogen on striatal dopamine neurotoxicity Ann N Y Acad Sci 844 153 165 9668673 10.1111/j.1749-6632.1998.tb08230.x 1:CAS:528:DyaK1cXks12ls78%3D (Pubitemid 28367804)
29. W Tripanichkul K Sripanichkulchai DI Finkelstein 2006 Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxication Brain Res 1084 28 37 16564034 10.1016/j.brainres.2006.02.029 1:CAS:528:DC%2BD28Xks1WltLg%3D
30. KM Dhandapani FM Wade VB Mahesh DW Brann 2005 Astrocyte-derived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways Endocrinology 146 2749 2759 15746252 10.1210/en.2005-0014 1:CAS:528: DC%2BD2MXkslehsr4%3D (Pubitemid 40695579)
31. B Marchetti PA Serra F L'Episcopo C Tirolo S Caniglia N Testa S Cioni F Gennuso G Rocchitta MS Desole MC Mazzarino E Miele MC Morale 2005 Hormones are key actors in gene × environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway Ann N Y Acad Sci 1057 296 318 16399902 10.1196/annals.1356.023 1:CAS:528: DC%2BD28XhvFGnur8%3D (Pubitemid 43211642)
32. B Marchetti F Gallo Z Farinella C Tirolo N Testa S Caniglia MC Morale 2000 Gender, neuroendocrine-immune interactions and neuron-glial plasticity: role of luteinizing hormone-releasing hormone (LHRH) Ann N Y Acad Sci 917 678 709 11268397 1:CAS:528:DC%2BD3cXovFymt7s%3D
33. M Bains JC Cousins JL Roberts 2007 Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERalpha in primary cultures of mouse mesencephalon Exp Neurol 204 767 776 17320868 10.1016/j.expneurol.2007. 01.020 1:CAS:528:DC%2BD2sXjslSku7w%3D (Pubitemid 46497065)